These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15882276)

  • 21. A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patients.
    Bargnoux AS; Morena M; Jaussent I; Maurice F; Chalabi L; Leray-Moragues H; Terrier N; Dupuy AM; Badiou S; Canaud B; Cristol JP
    Clin Chem Lab Med; 2013 Sep; 51(9):1865-74. PubMed ID: 23399590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Yu CM; Wang M; Chan IH; Zhang Y; Lui SF; Sanderson JE
    J Am Soc Nephrol; 2007 Jan; 18(1):321-30. PubMed ID: 17167121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease.
    Testa A; Spoto B; Tripepi G; Mallamaci F; Malatino L; Fatuzzo P; Maas R; Boeger R; Zoccali C
    J Hypertens; 2005 Oct; 23(10):1825-30. PubMed ID: 16148605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Wolzt M; Schernthaner G
    Diabetes Care; 2007 Jul; 30(7):1834-9. PubMed ID: 17456842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial dysfunction, inflammation and malnutrition markers as predictors of mortality in dialysis patients: multimarker approach.
    Ignjatović AM; Cvetković TP; Pavlović RM; Đorđević VM; Milošević ZG; Đorđević VB; Pavlović DD; Stojanović IR; Bogdanović D
    Int Urol Nephrol; 2013 Dec; 45(6):1715-24. PubMed ID: 23591722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
    Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
    Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac biomarkers and chronic renal diseases.
    Valocikova I; Kristofova B; Valocik G
    Bratisl Lek Listy; 2008; 109(8):341-4. PubMed ID: 18837240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
    Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure.
    Dückelmann C; Mittermayer F; Haider DG; Altenberger J; Eichinger J; Wolzt M
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):2037-42. PubMed ID: 17569878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.
    Takami Y; Horio T; Iwashima Y; Takiuchi S; Kamide K; Yoshihara F; Nakamura S; Nakahama H; Inenaga T; Kangawa K; Kawano Y
    Am J Kidney Dis; 2004 Sep; 44(3):420-8. PubMed ID: 15332214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M; Fleck C; Wolf G; Stein G
    Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic potential of brain natriuretic peptide (BNP) in predialysis chronic kidney disease patients.
    Carr SJ; Bavanandan S; Fentum B; Ng L
    Clin Sci (Lond); 2005 Jul; 109(1):75-82. PubMed ID: 15743271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between C-reactive protein levels and N-terminal pro-B-type natriuretic peptide in pre-dialysis patients.
    Ortega O; Gallar P; Muñoz M; Rodríguez I; Carreño A; Ortiz M; Molina A; Oliet A; Lozano L; Vigil A
    Nephron Clin Pract; 2004; 97(4):c125-30. PubMed ID: 15331941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular mortality and C-reactive protein in elderly patients beginning dialysis: reverse epidemiology?
    Millet C; Bosson JL; Pernod G; Wauters JP; Couturier P; Quesada JL; Zaoui P
    Aging Clin Exp Res; 2011; 23(5-6):357-63. PubMed ID: 22526070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.